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Genome-Wide Association Study of Orthostatic 
Hypotension and Supine-Standing Blood Pressure 
Changes in Two Korean Populations
Kyung-Won Hong, Sung Soo Kim, Yeonjung Kim*
Division of Epidemiology and Health Index, Center for Genome Science, Korea National Institute of Health, 
Korea Centers for Disease Control and Prevention, Cheongwon 363-951, Korea
Orthostatic hypotension (OH) is defined by a 20-mm Hg difference of systolic blood pressure (dtSBP) and/or a 10-mm Hg 
difference of diastolic blood pressure (dtDBP) between supine and standing, and OH is associated with a failure of the 
cardiovascular reflex to maintain blood pressure on standing from a supine position. To understand the underlying genetic 
factors for OH traits (OH, dtSBP, and dtDBP), genome-wide association studies (GWASs) using 333,651 single nucleotide 
polymorphisms (SNPs) were conducted separately for two population-based cohorts, Ansung (n = 3,173) and Ansan (n = 
3,255). We identified 8 SNPs (5 SNPs for dtSBP and 3 SNPs for dtDBP) that were repeatedly associated in both the Ansung and 
Ansan cohorts and had p-values of ＜1 × 10-5 in the meta-analysis. Unfortunately, the SNPs of the OH case control GWAS did 
not pass our p-value criteria. Four of 8 SNPs were located in the intergenic region of chromosome 2, and the nearest gene 
(CTNNA2) was located at 1 Mb of distance. CTNNA2 is a linker between cadherin adhesion receptors and the actin 
cytoskeleton and is essential for stabilizing dendritic spines in rodent hippocampal neurons. Although there is no report 
about the function in blood pressure regulation, hippocampal neurons interact primarily with the autonomic nervous system 
and might be related to OH. The remaining SNPs, rs7098785 of dtSBP trait and rs6892553, rs16887217, and rs4959677 of 
dtDBP trait were located in the PIK3AP1 intron, ACTBL2-3’ flanking, STAR intron, and intergenic region, respectively, but 
there was no clear functional link to blood pressure regulation.
Keywords: genome-wide association study, human CTNNA2 protein, orthostatic hypotension, single nucleotide poly-
morphism
Introduction
Orthostasis causes a gravitational shift in circulating 
blood from the intra-thoracic space to lower extremities and 
reduces venous return to the heart. This transient increase in 
sympathetic tone and decrease in parasympathetic tone and 
these normal cardiovascular reflexes cause an increase in 
heart rate and vascular resistance, restoring normal blood 
pressure (BP) and cardiac output [1]. Orthostatic hypo-
tension (OH) is the failure of the cardiovascular reflexes to 
maintain BP on standing from a supine position [2]. The 
Malmö Preventive Project reported that individuals with OH 
had significantly increased all-cause mortality (hazard ratio, 
1.4 to 1.6) [3]. 
OH has been defined by the international consensus as a 
decrease in systolic BP ≥ 20 mm Hg and/or a decrease in 
diastolic BP ≥ 10 mm Hg within 3 mintues of standing [4]. 
The prevalence of OH varies from 5% to 30%, depending 
greatly on the population being studied [5-7]. Aging is 
associated with a definite increase in the prevalence of OH 
and was reviewed in Benvenuto and Krakoff [2]. In addition 
to the aging effects, OH is more prevalent in hypertensive [8, 
9], neurological [10], and diabetic patients [11, 12]. The 
all-cause mortality rate was higher in patients with OH than 
in those without OH [6, 7]
We have been conducting an epidemiology study of OH as 
part of the Korean Genome and Epidemiology Study 
(KoGES) and previously reported that middle-aged adults 
(40‒70 years), enrolled from 2001 to 2002, had a 12.3% 
overall prevalence of OH and that the OH frequency in-
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creased significantly with age, from 6.4% in those aged 40‒
44 years to 23.1% in those aged 65‒69 (p ＜ 0.001) [9]. In 
addition, the study confirmed the correlations between OH 
and hypertension, body mass index (BMI), and type 2 
diabetes [9].
The genetic contribution to OH can be hypothesized that 
the frequency of OH in families with a history of essential 
hypertension is higher than in the general population [4]. A 
genetic association study was conducted by Luo et al. [13], 
and they identified a functional variant of NEDD4L (epi-
thelial sodium channel E3-ubiquitin ligase).
To identify genetic factors associated with OH trait in 
Koreans, we conducted genome-wide association studies 
(GWASs) for OH case controls using genome-wide single 
nucleotide polymorphism (SNP) genotypes and also tested 
supine and standing BPs as quantitative traits. 
Methods
Study subjects
The study subjects consisted of two population-based 
cohorts, Ansung and Ansan, which have been conducted as 
part of the KoGES. The phenotype of the cohort population 
was previously described [14]. Briefly, the subjects came 
from the Ansung and Ansan cities, located in Gyeonggi-do 
province near Seoul, Korea. Written informed consent was 
obtained from all participants, and this research project was 
approved by the institutional review board in the Korea 
National Institute of Health (KNIH).
Subjects with genotype accuracies below 98% and high 
missing genotype call rates (≥4%), high heterozygosity 
(>30%), or inconsistency in sex were excluded from 
subsequent analyses. Individuals who had a tumor were 
excluded, as were related individuals whose estimated 
identity-by-state values were high (>0.80). After these 
quality control steps, 8,842 samples were selected.
Clinical characteristics
BP was measured 3 times in the supine position. Before 
the first measurement, participants rested for 5 minutes, and 
the 3 measurements were taken in one arm showing the 
higher BP at least 3 minutes apart. After the supine position 
measurement, the BP was measured soon after standing. 
Two of 8,842 subjects did not undergo BP measurement in 
the standing posture. Also, 1,291 individuals who had been 
treated with anti-hypertensive drug therapy and 1,114 
self-reported diabetic patients or diagnosed diabetic patients 
by KoGES were excluded. Ultimately, 3,255 individuals from 
Ansan and 3,173 individuals from Ansung were used for the 
GWASs. Other cardiovascular risk factors, such as chole-
sterol level and fasting glucose level, were measured from 
blood samples after overnight fasting.
Study genotypes
The genotyping of the cohort population was previously 
described for the Korea Associated Resource (KARE) study 
[14]. Most DNA samples were isolated from the peripheral 
blood of participants and genotyped using the Affymetrix 
Genomewide Human SNP array 5.0 (Affymetrix, Inc., Santa 
Clara, CA, USA). The quality control steps of genotypes have 
been described elsewhere [14]. Briefly, the accuracy of the 
genotyping was determined by Bayesian Robust Linear 
Modeling using the Mahalanobis Distance (BRLMM) geno-
typing algorithm [15]. Consequently, 333,651 SNPs had a 
missing genotype call rate below 0.1, a minor allele 
frequency (MAF) greater than 0.01, and no deviation from 
Hardy-Weinberg equilibrium (HWE) (p > 1 × 10-6). To 
examine the population stratification, multidimensional 
scaling analysis and principal component analysis were 
performed using 44,724 pruned SNP markers [14].
Statistical analysis
The orthostatic BP changes were calculated by deltaBP = 
mean supine position BP － standing position BP. Delta 
systolic blood pressures (dtSBP), delta diastolic blood 
pressure (dtDBP), and OH cases (dtSBP ≥ 20 and/or dtDBP 
≥ 10 [16]) were analyzed by linear or logistic regression, 
controlling for covariates, such as age, sex, BMI, and systolic 
BP. Statistical analyses were performed using PLINK version 
1.07, using default options [17] and SPSS version 15.0 (SPSS 
Inc., Chicago, IL, USA). The GWAS were conducted for 
Ansan and Ansung separately. The Ansan GWAS and An-
sung replication study results were combined by inverse- 
variance meta-analysis method, assuming fixed effects, with 
Cochran’s Q test used to assess between-study hetero-
geneity [18]. The selected SNPs had a common MAF 
(>0.05) and the population heterogeneity (p > 0.05). The 
asymptotic HWE tests were conducted using PLINK, and all 
the reported p-values were two-sided.
Results
Clinical characteristics
Table 1 describes the clinical characteristics of OH case 
and control subjects in the Ansan and Ansung cohorts; 311 
participants (7.6%) and 496 participants (14.3%) were 
found to have OH in Ansan and Ansung, respectively. The 
gender distributions of OH differed significantly in both 
cohorts, and more male OH in Ansung and less male OH in 
Ansan were observed. The age of OH in Ansung (58.8 ± 7.8 
years) was older than that in Ansan (51.5 ± 8.3 years), 
reflecting the higher prevalence of OH in Ansung.
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Phenotype
Orthostatic hypotension
Ansan (n = 3,255) Ansung (n = 3,173) Ansan vs. Ansung
p-value　Control Case p-value Control Case p-value
n (%) 3,015 (92.6) 240 (7.4) - 2,746 (86.5) 427 (13.5) - -
Male (%) 1,517 (50.3) 106 (44.2) ＜0.01 1,114 (40.5) 269 (63.0) ＜0.001 ＜0.01
Age (y)  47.9 ± 7.4  51.3 ± 8.3 ＜0.001 54.8 ± 8.8  59.8 ± 7.8 ＜0.001 ＜0.001
Height (cm) 162.1 ± 8.4 159.6 ± 8.0 ＜0.001  158.6 ± 8.6 159.2 ± 8.2   0.1764 ＜0.001
Body mass index (kg/m2)  24.6 ± 2.9  24.4 ± 3.0   0.1860 24.3 ± 3.2  23.6 ± 3.3 ＜0.001   0.1860 
Supine SBP (mm Hg)  110.9 ± 15.9  119.4 ± 17.9 ＜0.001 118.9 ± 16.8  129.7 ± 16.5 ＜0.001 ＜0.001
Supine DBP (mm Hg)   71.8 ± 11.8   77.1 ± 11.4 ＜0.001 75.8 ± 9.9  81.4 ± 9.3 ＜0.001 ＜0.001
Standing SBP (mm Hg)  114.9 ± 16.6  105.2 ± 19.9 ＜0.001 116.9 ± 18.7  105.0 ± 16.2 ＜0.001 ＜0.001
Standing DBP (mm Hg)   77.6 ± 11.9   64.6 ± 14.7 ＜0.001  81.4 ± 13.0   75.2 ± 12.0 ＜0.001 ＜0.001
Delta SBP (mm Hg)    4.0 ± 10.6 －14.2 ± 14.3 ＜0.001 －2.1 ± 10.4 －24.7 ± 8.7 ＜0.001 ＜0.001
Delta DBP (mm Hg)   5.8 ± 8.4 －12.5 ± 9.5 ＜0.001  5.6 ± 8.8 －6.1 ± 9.9 ＜0.001 ＜0.001
Values are number (%) or mean ± SD.
SBP, systolic blood pressure; DBP, diastolic blood pressure.
Table 1. Clinical characteristics of orthostatic hypotension case controls in Ansan and Ansung cohorts phenotype
Fig. 1. Quantile-quantile plots and Man-
hattan plots of genomewide association
studies for delta systolic blood pressure
(A, D), delta diastolic blood pressure (B,
E), and orthostatic hypotension (C, F).
The BMI was significantly smaller in Ansung OH cases 
than controls, but it was not significant in Ansan. While the 
mean supine BP was significantly higher in OH than 
controls, the standing BP was significantly lower in OH than 
controls.
Genome-wide association studies
GWAS were conducted for each cohort, and the target 
phenotypes were dtSBP, dtDBP, and OH. The GWAS results 
of each cohort were combined by meta-analyses, and 
quantile-quantile plots and Manhattan plots are depicted in 
Fig. 1.
All detected SNPs are described in Table 2. Five SNPs for 
dtSBP trait and three SNPs for dtDBP trait passed our criteria 
(replicated in both cohorts [Ansung and Ansan] and p ＜ 1 × 
10-5), but unfortunately, the SNPs of the OH case control 
GWAS did not pass our p-value criteria. Among the signi-
ficant SNPs, four SNPs (rs6736587, rs6756959, rs6715049, 
and rs17020502) were in the high linkage disequilibrium 
status (r2 > 0.9) and were including the most significant 
SNP, rs6736587 (meta-analysis p-value, 5.3 × 10-8). The 
region of four SNPs was located in the intergenic region of 
chromosome 2, and the nearest gene (CTNNA2) was located 
at 1 Mb of distance. The remaining SNPs revealed a sug-
gestive association (p ＜ 1 × 10-5) with dtSBP at rs7098785 
(PIK3AP1 intron) and with dtDBP at rs6892553, rs16887217,
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Fig. 2. Signal plot of the most significant 
association with delta systolic blood 
pressure. SNP, single nucleotide poly-
morphism.
CHR RSID BP Proxy gene Function
Minor 
allele MAF Area Beta ± SE p-value Heterogenity Cochran Q
Delta SBP
 2 rs6736587 81709236 CTNNA2 Intergenic C 0.16 Ansan －1.74 ± 0.33 2.0 × 10-7
Ansung －0.89 ± 0.39 2.3 × 10-2
Meta-analysis －1.38 5.3 × 10-8 63.16 0.1
 2 rs6756959 81626234 CTNNA2 Intergenic A 0.155 Ansan －1.60 ± 0.34 2.2 × 10-6
Ansung －0.69 ± 0.40 8.8 × 10-2
Meta-analysis －1.22 2.2 × 10-6 67.14 0.08
 2 rs6715049 81626505 CTNNA2 Intergenic C 0.155 Ansan －1.57 ± 0.34 3.5 × 10-6
Ansung －0.67 ± 0.40 9.3 × 10-2
Meta-analysis －1.20 3.5 × 10-6 65.88 0.09
 2 rs17020502 81681572 CTNNA2 Intergenic A 0.06 Ansan －1.73 ± 0.51 6.7 × 10-4
Ansung －1.93 ± 0.61 1.7 × 10-3
Meta-analysis －1.81 3.7 × 10-6 0 0.8
10 rs7098785 98407920 PIK3AP1 Intron T 0.361 Ansan －0.76 ± 0.25 2.7 × 10-3
Ansung －1.10 ± 0.31 4.0 × 10-4
Meta-analysis －0.90 4.9 × 10-6 0 0.39
Delta DBP
5 rs6892553 56845895 ACTBL2 3’ Flanking G 0.137 Ansan   1.22 ± 0.30 5.2 × 10-5
Ansung   0.90 ± 0.34 8.5 × 10-3
Meta-analysis   1.08 1.8 × 10-6 0 0.48
8 rs16887217 38123582 STAR Intron C 0.105 Ansan   0.95 ± 0.34 4.7 × 10-3
Ansung   1.42 ± 0.37 1.5 × 10-4
Meta-analysis   1.16 3.5 × 10-6 0 0.35
6 rs4959677  2445819 MYLK4 Intergenic C 0.216 Ansan   0.97 ± 0.25 1.1 × 10-4
Ansung   0.65 ± 0.28 2.2 × 10-2
　 　 　 　 　 　 　 Meta-analysis   0.83 9.4 × 10-6 0 0.4
SNP, single nucleotide polymorphism; CHR, chromosome; RSID, reference SNP ID obtained from dbSNP database; BP, base pair 
based on the human reference genome, ver. 36 (NCBI); proxy gene, candidate functional gene around ±1 Mbp; MAF, minor allele 
frequency; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Table 2. Significant SNPs of genomewide association study and replication results
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and rs4959677, which were located in the ACTBL2 3' 
flanking, steroidogenic acute regulatory protein (STAR) 
intron, and intergenic regions (chromosome 6p 25.2), 
respectively.
Discussion
These normal baro-reflex responses cause an increase in 
heart rate and vascular resistance, restoring normal BP and 
cardiac output [1]. OH is the failure of the cardiovascular 
reflexes to maintain BP on standing from a supine position 
[2]. Also, the frequency of OH in families with a history of 
essential hypertension may be higher than in the general 
population [4]. Therefore, the identification of genetic factor 
for orthostasis will help us understand OH mechanisms.
The signal plot for the most significant SNP (rs6736587) 
is depicted in Fig. 2; the region was intergenic and a 
functional gene was located 1 Mbp upstream. Interestingly, 
this region is known as the chromosome 2p12-11.2 deletion 
syndrome region, and several cases report mental or psy-
chomotor retardation [19, 20]. There was only one gene, 
CTNNA2 (or known as alpha-N-catenin), around ±1 Mbp. 
CTNNA2 is a linker between cadherin adhesion receptors 
and the actin cytoskeleton and is essential for stabilizing 
dendritic spines in rodent hippocampal neurons [21]. 
Although there is no report about function in BP regulation, 
hippocampal neurons interact primarily with the autonomic 
nervous system. Therefore, the CTNNA2 gene may function 
in orthostatic BP regulation. 
Among the other SNPs, rs7098785 was located in the 
phosphoinositide-3-kinase adaptor protein 1 (PIK3AP1) 
gene. PIK3AP1 is involved in B-cell development [22]. 
Interestingly, in silico analyses by the UCSC genome browser 
(http://genome.ucsc.edu/) indicated that the SNP was 
located in a DNase I hypersensitive region and in the binding 
site of transcription factors (MEF2C, BATF, MEF2A). 
Therefore, the rs7098785 SNP might have a regulatory 
function of PIK3AP1 expression. 
The remaining three SNPs of dtDBP were located in the 
ACTBL2 (beta-actin like protein 2) 3' flanking region, STAR 
intron, and intergenic region (chromosome 6p 25.2). The 
ACTBL2 protein is involved in various types of cell motility 
[23], and STAR is involved in the regulation of steroid 
hormone synthesis [24]. 
Our study was the first trial to identify genetic variants for 
orthostatic BP traits in Koreans. We hope that our finding 
could help us understand the underlying mechanism of 
orthostatic BP changes and related diseases.
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